Unlock stock picks and a broker-level newsfeed that powers Wall Street.

KSE - Delayed Quote KRW

Samsung Biologics Co.,Ltd. (207940.KS)

1,075,000.00
+3,000.00
+(0.28%)
At close: 3:30:03 PM GMT+9
Currency in KRW All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
4,547,322,176.42
4,547,322,176.42
3,694,588,767.06
3,001,295,197.68
1,568,006,928.03
Cost of Revenue
2,256,477,586.44
2,256,477,586.44
1,891,824,205.77
1,532,847,164.86
841,555,562.59
Gross Profit
2,290,844,589.98
2,290,844,589.98
1,802,764,561.29
1,468,448,032.82
726,451,365.44
Operating Expense
970,792,209.77
970,792,209.77
689,084,551.47
484,820,638
189,141,957
Operating Income
1,320,052,380.21
1,320,052,380.21
1,113,680,009.82
983,627,394.82
537,309,408.44
Net Non Operating Interest Income Expense
13,781,849.43
13,781,849.43
14,053,655.22
-10,771,705.45
-5,051,266.66
Pretax Income
1,370,051,625.75
1,370,051,625.75
1,119,986,931.20
1,009,024,573.71
561,282,597.29
Tax Provision
286,735,739.76
286,735,739.76
262,295,632.81
210,968,363.63
167,693,129.63
Net Income Common Stockholders
1,083,315,885.98
1,083,315,885.98
857,691,298.38
798,056,210.08
393,589,467.65
Basic EPS
15.22k
--
12.05k
11.44k
5.89k
Diluted EPS
15.22k
--
12.05k
11.43k
5.89k
Basic Average Shares
71,172.45
--
71,171.80
69,747.97
66,862.91
Diluted Average Shares
71,172.45
--
71,171.80
69,808.98
66,862.91
Total Operating Income as Reported
1,320,052,380.13
1,320,052,380.13
1,113,680,009.71
983,627,394.37
537,309,408.07
Total Expenses
3,227,269,796.21
3,227,269,796.21
2,580,908,757.24
2,017,667,802.86
1,030,697,519.59
Net Income from Continuing & Discontinued Operation
1,083,315,885.98
1,083,315,885.98
857,691,298.38
798,056,210.08
393,589,467.65
Normalized Income
1,120,618,334.30
1,120,618,334.30
859,691,123.41
740,492,868.45
395,617,876.65
Interest Income
63,839,149.22
63,839,149.22
95,650,057.42
53,292,640
9,655,916
Interest Expense
50,057,299.79
50,057,299.79
81,596,402.20
64,064,346
14,707,182
Net Interest Income
13,781,849.43
13,781,849.43
14,053,655.22
-10,771,705.45
-5,051,266.66
EBIT
1,420,108,925.54
1,420,108,925.54
1,201,583,333.40
1,073,088,919.71
575,989,779.29
EBITDA
2,019,210,069.85
2,019,210,069.85
1,691,365,328.05
1,381,353,240.61
737,778,429.15
Reconciled Cost of Revenue
2,256,477,586.44
2,256,477,586.44
1,891,824,205.77
1,532,847,164.86
841,555,562.59
Reconciled Depreciation
599,101,144.31
599,101,144.31
489,781,994.65
308,264,320.90
161,788,649.86
Net Income from Continuing Operation Net Minority Interest
1,083,315,885.98
1,083,315,885.98
857,691,298.38
798,056,210.08
393,589,467.65
Total Unusual Items Excluding Goodwill
-47,175,787.44
-47,175,787.44
-2,611,403.31
72,780,370
-2,892,635
Total Unusual Items
-47,175,787.44
-47,175,787.44
-2,611,403.31
72,780,370
-2,892,635
Normalized EBITDA
2,066,385,857.29
2,066,385,857.29
1,693,976,731.36
1,308,572,870.61
740,671,064.15
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-9,873,339.12
-9,873,339.12
-611,578.28
15,217,028.37
-864,226
12/31/2021 - 11/11/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

19X.SG Axsome Therapeutics Inc
90.74
-1.28%
 
300871.SZ Hvsen Biotechnology Co., Ltd.
22.98
+2.41%
 
96X.F FluoGuide A/S
3.3000
+4.10%
 
6660.HK AIM Vaccine Co., Ltd.
3.280
+2.50%
 
2171.HK CARsgen Therapeutics Holdings Limited
14.800
+16.17%
 
2157.HK Lepu Biopharma Co., Ltd.
4.230
+6.82%
 
9966.HK Alphamab Oncology
6.960
+4.98%
 
2142.HK HBM Holdings Limited
8.110
+12.95%
 
1530.HK 3SBIO
12.520
+4.68%
 
196170.KQ ALTEOGEN Inc.
389,000.00
+0.65%